Cargando…

Linc00152 promotes malignant progression of glioma stem cells by regulating miR-103a-3p/FEZF1/CDC25A pathway

BACKGROUND: Glioma is one of the most frequent intracranial malignant tumors. LncRNAs have been identified as new modulators in the origination and progression of glioma. METHODS: Quantitative real-time PCR were conducted to evaluate the expression of linc00152 and miRNA-103a-3p in glioma tissues an...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Mingjun, Xue, Yixue, Zheng, Jian, Liu, Xiaobai, Yu, Hai, Liu, Libo, Li, Zhen, Liu, Yunhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485714/
https://www.ncbi.nlm.nih.gov/pubmed/28651608
http://dx.doi.org/10.1186/s12943-017-0677-9
_version_ 1783246124879970304
author Yu, Mingjun
Xue, Yixue
Zheng, Jian
Liu, Xiaobai
Yu, Hai
Liu, Libo
Li, Zhen
Liu, Yunhui
author_facet Yu, Mingjun
Xue, Yixue
Zheng, Jian
Liu, Xiaobai
Yu, Hai
Liu, Libo
Li, Zhen
Liu, Yunhui
author_sort Yu, Mingjun
collection PubMed
description BACKGROUND: Glioma is one of the most frequent intracranial malignant tumors. LncRNAs have been identified as new modulators in the origination and progression of glioma. METHODS: Quantitative real-time PCR were conducted to evaluate the expression of linc00152 and miRNA-103a-3p in glioma tissues and cells. Western blot were used to determine the expression of FEZF1 and CDC25A in glioma tissues and cells. Stable knockdown of linc00152 or over-expression of miR-103a-3p in glioma stem cells (GSCs) were established to explore the function of linc00152 and miR-103a-3p in GSCs. Further, luciferase reports were used to investigate the correlation between linc00152 and miR-103a-3p. Cell Counting Kit-8, transwell assays, and flow cytometry were used to investigate the function of linc00152 and miR-103a-3p in GSC malignant biological behaviors. ChIP assays were employed to ascertain the correlations between FEZF1 and CDC25A. RESULTS: Linc00152 was up-regulated in glioma tissues as well as in GSCs. Knockdown of linc00152 inhibited cell proliferation, migration and invasion, while promoted GSC apoptosis. Linc00152 regulated the malignant behavior of GSCs by binding to miR-103a-3p, which functions as a tumor suppressor. In addition, knockdown of linc00152 down-regulated forebrain embryonic zinc finger protein 1 (FEZF1), a direct target of miR-103a-3p which played an oncogenic role in GSCs. FEZF1 elevated promoter activities and up-regulated expression of the oncogenic gene cell division cycle 25A (CDC25A). CDC25A over-expression activated the PI3K/AKT pathways, which regulated the malignant behavior of GSCs. CONCLUSIONS: Linc00152/miR-103a-3p/FEZF1/CDC25A axis plays a novel role in regulating the malignant behavior of GSCs, which may be a new potential therapeutic strategy for glioma therapy. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12943-017-0677-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5485714
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-54857142017-06-30 Linc00152 promotes malignant progression of glioma stem cells by regulating miR-103a-3p/FEZF1/CDC25A pathway Yu, Mingjun Xue, Yixue Zheng, Jian Liu, Xiaobai Yu, Hai Liu, Libo Li, Zhen Liu, Yunhui Mol Cancer Research BACKGROUND: Glioma is one of the most frequent intracranial malignant tumors. LncRNAs have been identified as new modulators in the origination and progression of glioma. METHODS: Quantitative real-time PCR were conducted to evaluate the expression of linc00152 and miRNA-103a-3p in glioma tissues and cells. Western blot were used to determine the expression of FEZF1 and CDC25A in glioma tissues and cells. Stable knockdown of linc00152 or over-expression of miR-103a-3p in glioma stem cells (GSCs) were established to explore the function of linc00152 and miR-103a-3p in GSCs. Further, luciferase reports were used to investigate the correlation between linc00152 and miR-103a-3p. Cell Counting Kit-8, transwell assays, and flow cytometry were used to investigate the function of linc00152 and miR-103a-3p in GSC malignant biological behaviors. ChIP assays were employed to ascertain the correlations between FEZF1 and CDC25A. RESULTS: Linc00152 was up-regulated in glioma tissues as well as in GSCs. Knockdown of linc00152 inhibited cell proliferation, migration and invasion, while promoted GSC apoptosis. Linc00152 regulated the malignant behavior of GSCs by binding to miR-103a-3p, which functions as a tumor suppressor. In addition, knockdown of linc00152 down-regulated forebrain embryonic zinc finger protein 1 (FEZF1), a direct target of miR-103a-3p which played an oncogenic role in GSCs. FEZF1 elevated promoter activities and up-regulated expression of the oncogenic gene cell division cycle 25A (CDC25A). CDC25A over-expression activated the PI3K/AKT pathways, which regulated the malignant behavior of GSCs. CONCLUSIONS: Linc00152/miR-103a-3p/FEZF1/CDC25A axis plays a novel role in regulating the malignant behavior of GSCs, which may be a new potential therapeutic strategy for glioma therapy. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12943-017-0677-9) contains supplementary material, which is available to authorized users. BioMed Central 2017-06-26 /pmc/articles/PMC5485714/ /pubmed/28651608 http://dx.doi.org/10.1186/s12943-017-0677-9 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Yu, Mingjun
Xue, Yixue
Zheng, Jian
Liu, Xiaobai
Yu, Hai
Liu, Libo
Li, Zhen
Liu, Yunhui
Linc00152 promotes malignant progression of glioma stem cells by regulating miR-103a-3p/FEZF1/CDC25A pathway
title Linc00152 promotes malignant progression of glioma stem cells by regulating miR-103a-3p/FEZF1/CDC25A pathway
title_full Linc00152 promotes malignant progression of glioma stem cells by regulating miR-103a-3p/FEZF1/CDC25A pathway
title_fullStr Linc00152 promotes malignant progression of glioma stem cells by regulating miR-103a-3p/FEZF1/CDC25A pathway
title_full_unstemmed Linc00152 promotes malignant progression of glioma stem cells by regulating miR-103a-3p/FEZF1/CDC25A pathway
title_short Linc00152 promotes malignant progression of glioma stem cells by regulating miR-103a-3p/FEZF1/CDC25A pathway
title_sort linc00152 promotes malignant progression of glioma stem cells by regulating mir-103a-3p/fezf1/cdc25a pathway
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485714/
https://www.ncbi.nlm.nih.gov/pubmed/28651608
http://dx.doi.org/10.1186/s12943-017-0677-9
work_keys_str_mv AT yumingjun linc00152promotesmalignantprogressionofgliomastemcellsbyregulatingmir103a3pfezf1cdc25apathway
AT xueyixue linc00152promotesmalignantprogressionofgliomastemcellsbyregulatingmir103a3pfezf1cdc25apathway
AT zhengjian linc00152promotesmalignantprogressionofgliomastemcellsbyregulatingmir103a3pfezf1cdc25apathway
AT liuxiaobai linc00152promotesmalignantprogressionofgliomastemcellsbyregulatingmir103a3pfezf1cdc25apathway
AT yuhai linc00152promotesmalignantprogressionofgliomastemcellsbyregulatingmir103a3pfezf1cdc25apathway
AT liulibo linc00152promotesmalignantprogressionofgliomastemcellsbyregulatingmir103a3pfezf1cdc25apathway
AT lizhen linc00152promotesmalignantprogressionofgliomastemcellsbyregulatingmir103a3pfezf1cdc25apathway
AT liuyunhui linc00152promotesmalignantprogressionofgliomastemcellsbyregulatingmir103a3pfezf1cdc25apathway